Question follow-through · 562
Urinary Tract Infections: Preventive Medicine
To ask the Secretary of State for Health and Social Care, whether any (a) vaccines and (b) alternative preventative treatments for recurrent urinary tract infections are (i) currently under review by UK regulatory bodies and (ii) expected to enter the UK
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 13 May 2026
- Target answer date
- 18 May 2026
- Answer
- 18 May 2026 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Heart Diseases: Prescriptions · 8 Jun 2026
- Heart Diseases: Prescriptions · 8 Jun 2026
- Heart Diseases: Young People · 9 Jun 2026
- Brain Cancer: Children · 10 Jun 2026
- Hydrocortisone · 15 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
13 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether any (a) vaccines and (b) alternative preventative treatments for recurrent urinary tract infections are (i) currently under review by UK regulatory bodies and (ii) expected to enter the UK
18 May 2026
Target answer date
Date supplied by the official written-questions record.
18 May 2026
Answer published
The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet ap...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Heart Diseases: Prescriptions
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether his Department plans to review the current criteria for medical exemption certificates for prescription charges to include Arrhythmogenic Cardiomyopathy.
Heart Diseases: Prescriptions
8 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment has been made of the potential impact on patient health outcomes if individuals with Arrhythmogenic Cardiomyopathy are unable to afford their prescribed medication.
Heart Diseases: Young People
9 Jun 2026 · To ask the Secretary of State for Health and Social Care, what plans his Department has for a national strategy for the prevention of Young Sudden Cardiac Death.
Brain Cancer: Children
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will ringfence protected funding for children's brain cancer research separate from wider cancer budgets.
Hydrocortisone
15 Jun 2026 · To ask the Secretary of State for Health and Social Care, with the withdrawal of liquid hydrocortisone what steps is his department is taking to source a suitable alternative liquid hydrocortisone product for use in the UK.
Hydrocortisone
15 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will work with Pfizer to accelerate the UK licensing of the ‘ACT-O-VIAL’ dual-compartment hydrocortisone product containing pre-measured doses of powder and water for immediate mixing.
Hydrocortisone
15 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking, in collaboration with the Office for Life Sciences, to support and fast-track the development of safer hydrocortisone delivery methods; and what assessment he h
Sexual and Reproductive Health
22 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of NHS psychosexual services; and what steps he is taking to help reduce regional disparities in access to such services.
Sexual and Reproductive Health
22 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of psychosexual services on demand for gynaecology, urology and fertility services.
Sexual and Reproductive Health
22 Jun 2026 · To ask the Secretary of State for Health and Social Care, how many NHS psychosexual services have been decommissioned in each of the last five years; and what assessment he has made of the potential impact of those closures on patient outcomes.
Sexual and Reproductive Health
22 Jun 2026 · To ask the Secretary of State for Health and Social Care, what estimate he has made of the potential cost savings to the NHS from the provision of specialist psychosexual services.
Sexual and Reproductive Health
22 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients referred to psychosexual services under NICE guidance are able to access those services within a reasonable timeframe.